Mycophenolate Mofetil as First-Line Therapy for Ocular Myasthenia Gravis

Update Item Information
Identifier 20110208_nanos_posters_104
Title Mycophenolate Mofetil as First-Line Therapy for Ocular Myasthenia Gravis
Creator De Lott, Lindsey; Antonio-Santos, Aileen; Eggenberger, Eric; Calvert, Preston; Cornblath, Wayne
Subject Myasthenia; Mycophenolate
Description Ocular myasthenia gravis (OMG) may produce debilitating diplopia or ptosis leading to significant visual disability. Symptomatic treatment with pyridostigmine is frequently ineffective and immunosuppressive therapy with corticosteroids can have serious side-effects.
Date 2011-02-08
Language eng
Format application/pdf
Format Creation application/pdf
Type Text
Source 2011 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2011: Poster Presentations
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2011. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6fj5p98
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 181798
Reference URL https://collections.lib.utah.edu/ark:/87278/s6fj5p98
Back to Search Results